THE "NEW" DRUG CLASSES IN THE TREATMENT OF CHRONIC HEART FAILURE AND THEIR EVIDENCE BASE

THE "NEW" DRUG CLASSES IN THE TREATMENT OF CHRONIC HEART FAILURE AND THEIR EVIDENCE BASE

Show other versions (1)

<p>A comparison of ivabradine and omega-3 polyunsaturated fatty acids, drugs with principally different mechanisms of action, is presented in patients with chronic heart failure (CHF) on the base of GISSI-HF and SHIFT trails results. It is essential to compaire an effect of these drugs on the...

Full description

Bibliographic Details
Main Authors: S. N. Tereshchenko, I. V. Zhirov, A. G. Kochetov, O. V. Uspenskaya
Format: Article
Language:English
Published: Stolichnaya Izdatelskaya Kompaniya 2015-12-01
Series:Racionalʹnaâ Farmakoterapiâ v Kardiologii
Subjects:
хроническая сердечная недостаточность
рандомизированное клиническое исследование
ивабрадин
омега-3 полиненасыщенные жирные кислоты
Online Access:http://www.rpcardio.ru/jour/article/view/561

Internet

http://www.rpcardio.ru/jour/article/view/561

Similar Items